GlassScriptPhysician profile
Christopher A Durham
NPI 1699979419
$14,249.42
in general payments reported to CMS, 2019-2025
19 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $2,049 · 2021: $2,109 · 2022: $5,978 · 2023: $3,548 · 2024: $176 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,125 · Food and Beverage: $515 · Travel and Lodging: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,125.00 |
| Food and Beverage | $515.28 |
| Travel and Lodging | $327.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $7,354.21 | 2020-2022 | |
| Getinge USA Sales, LLC | $5,266.37 | 2020-2023 | Icast |
| W. L. Gore & Associates, INC. | $359.98 | 2019-2022 | |
| Medtronic, INC. | $325.63 | 2021-2022 | |
| Medtronic Vascular, INC. | $192.36 | 2019-2020 | |
| Cardiovascular Systems INC. | $141.73 | 2020-2023 | Diamondback Peripheral |
| Lemaitre Vascular, INC. | $116.74 | 2021-2025 | Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium), Restoreflow |
| Bard Peripheral Vascular, INC. | $96.97 | 2023-2024 | Covera |
| Angiodynamics, INC. | $82.54 | 2025 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $58.47 | 2024 | Indigo System |
| Eisai INC. | $51.00 | 2024 | |
| Abbott Laboratories | $39.71 | 2023-2025 | Diamondback Peripheral |
| Horizon Therapeutics Plc | $33.96 | 2021 | |
| Argon Medical Devices, INC. | $30.05 | 2025 | Clot Management |
| Vifor Pharma, INC. | $25.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $22.98 | 2022 | |
| Becton, Dickinson and Company | $22.68 | 2025 | Rotarexs 6 F X 135 Cm |
| Tela Bio, INC. | $17.09 | 2024 | Ovitex 2s |
| Philips North America LLC | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.